VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling

Human Glioma Growth Is Controlled by MicroRNA-10b

(2011) G. Gabriely et al.   CANCER RESEARCH

High  -catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression

(2011) J. Zhang et al.   NEURO-ONCOLOGY

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

(2011) H-J Kwak et al.   ONCOGENE

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

(2011) Olivier Keunen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma

(2010) E. G. Van Meir et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

A cross-disciplinary approach to understanding neural stem cells in development and disease

(2010) D. Henrique et al.   DEVELOPMENT

Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status

(2010) Xuan Zhou et al.   LABORATORY INVESTIGATION

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

(2010) Chun-Zhi Zhang et al.   Molecular Cancer

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy

(2009) A. K. Lucio-Eterovic et al.   CLINICAL CANCER RESEARCH

Oxygen-independent degradation of HIF-αviabioengineered VHL tumour suppressor complex

(2009) Roxana I. Sufan et al.   EMBO Molecular Medicine

Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms

(2009) Hrvoje Miletic et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Three Immunomarker Support Vector Machines–Based Prognostic Classifiers for Stage IB Non–Small-Cell Lung Cancer

(2009) Zhi-Hua Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY

EGF-Induced ERK Activation Promotes CK2-Mediated Disassociation of α-Catenin from β-Catenin and Transactivation of β-Catenin

(2009) Haitao Ji et al.   MOLECULAR CELL

The Emerging Role of Anti-Angiogenic Therapy for Malignant Glioma†

(2008) David A. Reardon et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

(2008) G. Gabriely et al.   MOLECULAR AND CELLULAR BIOLOGY

Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL

(2008) Vipul C. Chitalia et al.   NATURE CELL BIOLOGY